Prognostic value of PD-L1 overexpression for pancreatic cancer: evidence from a meta-analysis

Programmed death-ligand 1 (PD-L1) is an immune checkpoint that is often activated in cancer and plays a pivotal role in the initiation and progression of cancer. However, the clinicopathologic significance and prognostic value of PD-L1 in pancreatic cancer (PC) remains controversial. In this study,...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhuan-Sun, Yongxun, Huang, Fengting, Feng, Min, Zhao, Xinbao, Chen, Wenying, Zhu, Zhe, Zhang, Shineng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5652904/
https://www.ncbi.nlm.nih.gov/pubmed/29081663
http://dx.doi.org/10.2147/OTT.S146383

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5652904/
https://www.ncbi.nlm.nih.gov/pubmed/29081663
http://dx.doi.org/10.2147/OTT.S146383

Ejemplares similares